Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease have?
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease has 140 citations in the OpenAlex counts ScholarIQ stores.
When was Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease published?
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease has 2024 year in the ScholarIQ index.
What is the open-access status of Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease?
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease has closed oa status in the ScholarIQ index.
What is the DOI of Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease?
The DOI for Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease is on the source record.
What is the PMID of Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease?
The PMID for Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease is on the source record.
What is the OpenAlex record for Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease?
The OpenAlex for Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease is on the source record.